What is Innovative Genomics Institute's contact information?

Innovative Genomics Institute's contact information: +15109826715.

How many employees does Innovative Genomics Institute have?

Innovative Genomics Institute has 300 employees.

What industry does Innovative Genomics Institute belong to?

Innovative Genomics Institute is in the industry of: Research.

What are Innovative Genomics Institute's official social media profiles?

Innovative Genomics Institute Linkedin Page Innovative Genomics Institute Twitter Page

What tech stack does Innovative Genomics Institute use?

Some of the popular technologies that Innovative Genomics Institute uses are: ExactMetrics, WordPress, Fastly, Cloudflare.

What are Innovative Genomics Institute's office addresses?

Innovative Genomics Institute has 2 known office addresses: 2151 Berkeley Way Berkeley, California 94720-3370, US 2151 Berkeley Way, Berkeley, California 94720-3370, Us.

What is Innovative Genomics Institute's estimated annual revenue?

Innovative Genomics Institute's revenue is $6,165,000

What is Innovative Genomics Institute's open headcount?

Innovative Genomics Institute has no job postings yet.

What is the number of ad campaigns for Innovative Genomics Institute?

Innovative Genomics Institute has no advertisements yet.

What is the number of recent news articles about Innovative Genomics Institute?

Innovative Genomics Institute has 2 news articles.

Innovative Genomics Institute - Pubrio Company Profile & Intent

Innovative Genomics Institute

United States · Research

Research

The Innovative Genomics Institute (IGI) is a nonprofit scientific research organization established in 2015 by Nobel Laureate Jennifer Doudna and biophysicist Jonathan Weissman. Based at the University of California, Berkeley, IGI collaborates with various institutions, including UC San Francisco and UCLA, to advance CRISPR-based genome engineering for real-world applications. IGI's mission focuses on addressing global challenges in human health, climate resilience, and sustainable agriculture. The organization develops CRISPR-based therapies for genetic diseases, engineers crops for improved climate adaptation, and creates next-generation genome editing tools. Their offerings include CRISPR delivery technologies, diagnostic tools for rapid disease detection, and gene-edited crops designed for enhanced resilience. The IGI emphasizes equitable access to its innovations, aiming to benefit underserved populations.